[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,917,912
  • Shares Outstanding, K 575,800
  • Annual Sales, $ 6,068 M
  • Annual Income, $ 1,074 M
  • EBIT $ 1,347 M
  • EBITDA $ 1,504 M
  • 60-Month Beta 0.86
  • Price/Sales 9.00
  • Price/Cash Flow 33.25
  • Price/Book 5.29

Options Overview Details

View History
  • Implied Volatility 38.15% (+4.91%)
  • Historical Volatility 24.40%
  • IV Percentile 90%
  • IV Rank 71.61%
  • IV High 46.09% on 10/24/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 7) 2.25 (2.47%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 606
  • Volume Avg (30-Day) 865
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 45,981
  • Open Int (30-Day) 48,887
  • Expected Range 89.08 to 93.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.73
  • Number of Estimates 9
  • High Estimate $0.75
  • Low Estimate $0.72
  • Prior Year $0.67
  • Growth Rate Est. (year over year) +8.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.17 +9.81%
on 06/12/26
96.29 -5.15%
on 07/07/26
+3.79 (+4.33%)
since 06/09/26
3-Month
76.49 +19.40%
on 05/11/26
96.29 -5.15%
on 07/07/26
+12.18 (+15.39%)
since 04/09/26
52-Week
72.30 +26.32%
on 10/13/25
96.29 -5.15%
on 07/07/26
+14.14 (+18.32%)
since 07/09/25

Most Recent Stories

More News
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

EW : 91.33 (-2.47%)
What You Need To Know Ahead of Edwards Lifesciences' Earnings Release

Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.

EW : 91.33 (-2.47%)
XLV : 162.17 (-0.08%)
$SPX : 7,543.64 (+0.81%)
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership...

EW : 91.33 (-2.47%)
Stocks Indexes Finish Mostly Lower as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.89%. June E-mini...

TSCO : 30.12 (+1.83%)
OXY : 52.30 (-2.41%)
PLAY : 10.55 (+4.04%)
FANG : 182.00 (-2.47%)
AMD : 546.72 (+5.67%)
SPY : 751.71 (+0.85%)
MU : 991.64 (+4.52%)
BKR : 57.20 (-0.66%)
ORCL : 144.22 (+2.65%)
QQQ : 723.28 (+1.66%)
EW : 91.33 (-2.47%)
SPCX : 152.16 (+2.60%)
Broader Market Weakens as Energy and Software Stocks Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.83%. June E-mini S&P futures (ESM26...

ALK : 50.14 (+5.49%)
HL : 15.79 (+4.64%)
CDE : 16.02 (+5.12%)
TSCO : 30.12 (+1.83%)
OXY : 52.30 (-2.41%)
PLAY : 10.55 (+4.04%)
FANG : 182.00 (-2.47%)
SPY : 751.71 (+0.85%)
BKR : 57.20 (-0.66%)
ORCL : 144.22 (+2.65%)
AAL : 17.06 (+3.27%)
QQQ : 723.28 (+1.66%)
Stocks Supported by Lower Crude Oil Prices and Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26...

ALK : 50.14 (+5.49%)
MPC : 283.30 (+0.93%)
SNDK : 1,858.27 (+7.59%)
HL : 15.79 (+4.64%)
CDE : 16.02 (+5.12%)
ADI : 393.64 (+2.14%)
TSCO : 30.12 (+1.83%)
PLAY : 10.55 (+4.04%)
FANG : 182.00 (-2.47%)
STX : 890.09 (+3.50%)
WDC : 578.05 (+5.04%)
SCCO : 174.43 (+4.32%)
Is Edwards Lifesciences Stock Underperforming the Nasdaq?

Despite trailing the broader Nasdaq Composite over the last 12 months, Edwards Lifesciences continues to earn strong support from analysts.

EW : 91.33 (-2.47%)
$NASX : 26,206.89 (+1.30%)
SYK : 327.11 (+0.08%)
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

While Edwards Lifesciences has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

EVR : 339.75 (+2.63%)
EW : 91.33 (-2.47%)
XLV : 162.17 (-0.08%)
$SPX : 7,543.64 (+0.81%)
Edwards Lifesciences Announces Appointment of CFO

Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company’s corporate vice president and chief financial officer (CFO), effective at the end of...

EW : 91.33 (-2.47%)
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data...

EW : 91.33 (-2.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 94.88
2nd Resistance Point 94.05
1st Resistance Point 92.69
Last Price 91.33
1st Support Level 90.50
2nd Support Level 89.67
3rd Support Level 88.31

See More

52-Week High 96.29
Last Price 91.33
Fibonacci 61.8% 87.13
Fibonacci 50% 84.29
Fibonacci 38.2% 81.46
52-Week Low 72.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.